Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today
- PMID: 20056622
- PMCID: PMC2939494
- DOI: 10.1158/1055-9965.EPI-09-0520
Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today
Abstract
Background: Radiotherapy during childhood increases long-term cancer risk, but the risk from radiation as a result of relatively higher dose diagnostic procedures remains less well known. This study, which evaluates breast cancer incidence in a cohort treated with "lower dose" chest radiotherapy over 50 years ago, can assist with estimating lifetime breast cancer risk in young children exposed to radiation from procedures such as chest computed tomography (CT) or treatment with recent "lower dose" chest radiotherapy protocols.
Methods: A population-based, longitudinal cohort of subjects exposed to thymic irradiation during infancy from 1926 to 1957 and of their unexposed siblings was re-established. Previously followed until 1987, we resurveyed cohort members from 2004 to 2008. Poisson regression models compared breast cancer incidence rates between women in the cohort by treatment and dose category groups.
Results: Breast cancer occurred in 96 treated (mean breast dose, 0.71 Gy) and 57 untreated women during 159,459 person-years of follow-up. After adjusting for attained age and treatment/birth cohort, the rate ratio was 3.01 (2.18-4.21). The adjusted excess relative risk per Gy was 1.10 (95% confidence interval, 0.61-1.86). Traditional breast cancer risk factors did not contribute significantly to multivariate model fit.
Conclusion: Our results show that at radiation doses between those received by the breast from chest CT and cancer therapy during early childhood, breast cancer incidence rates remain elevated >50 years after exposure. This implies that increased breast cancer risk will remain a lifelong concern in females treated during childhood with currently reduced radiotherapy doses and for infants receiving multiple chest CTs.
Figures

Similar articles
-
Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort.Radiat Res. 2010 Dec;174(6):753-62. doi: 10.1667/RR2181.1. Epub 2010 Oct 26. Radiat Res. 2010. PMID: 21128799 Free PMC article.
-
The risk of breast cancer after irradiation of the thymus in infancy.N Engl J Med. 1989 Nov 9;321(19):1281-4. doi: 10.1056/NEJM198911093211901. N Engl J Med. 1989. PMID: 2797100
-
Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease.J Natl Cancer Inst. 1993 Oct 20;85(20):1679-85. doi: 10.1093/jnci/85.20.1679. J Natl Cancer Inst. 1993. PMID: 8411245
-
Cancer risks from medical radiation.Health Phys. 2003 Jul;85(1):47-59. doi: 10.1097/00004032-200307000-00011. Health Phys. 2003. PMID: 12852471 Review.
-
[Epidemiologic data on radiation-induced breast cancer].Rev Epidemiol Sante Publique. 2008 Aug;56(4):235-43. doi: 10.1016/j.respe.2008.05.024. Epub 2008 Jul 30. Rev Epidemiol Sante Publique. 2008. PMID: 18672338 Review. French.
Cited by
-
Risk of Coronary Events 55 Years after Thymic Irradiation in the Hempelmann Cohort.Cardiooncology. 2018;4:1. doi: 10.1186/s40959-018-0027-0. Epub 2018 Feb 17. Cardiooncology. 2018. PMID: 30381795 Free PMC article.
-
Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.J Radiol Prot. 2014 Jun;34(2):R25-52. doi: 10.1088/0952-4746/34/2/R25. Epub 2014 Apr 14. J Radiol Prot. 2014. PMID: 24727460 Free PMC article. Review.
-
Modulation of VEGF Expression and Oxidative Stress Response by Iodine Deficiency in Irradiated Cancerous and Non-Cancerous Breast Cells.Int J Mol Sci. 2020 May 31;21(11):3963. doi: 10.3390/ijms21113963. Int J Mol Sci. 2020. PMID: 32486504 Free PMC article.
-
A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure.Radiat Res. 2024 Aug 1;202(2):432-487. doi: 10.1667/RADE-24-00021.1. Radiat Res. 2024. PMID: 39021204 Free PMC article. Review.
-
Frequent MUGA testing in a myeloma patient: A case-based ethics discussion.J Nucl Cardiol. 2017 Aug;24(4):1350-1354. doi: 10.1007/s12350-016-0540-1. Epub 2016 Jun 6. J Nucl Cardiol. 2017. PMID: 27272150 No abstract available.
References
-
- Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD., Jr Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res. 2002;158:220–35. - PubMed
-
- van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol. 1994;12:312–25. - PubMed
-
- Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465–75. - PubMed
-
- Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005;97:1428–37. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials